Cargando...
Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy
OBJECTIVE: To test the hypothesis that the intrathecal synthesis of free light chain kappa (FLC-k) can be used as a CSF biomarker to differentiate patients with myelitis due to multiple sclerosis (MS), myelitis due to neuromyelitis optica spectrum disease (NMOSD), and noninflammatory myelopathy, we...
Guardado en:
| Publicado en: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7524577/ https://ncbi.nlm.nih.gov/pubmed/32948648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000892 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|